How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

BLOG
How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
Uncovering insights in the pharmaceutical industry, including optimizing supply chain solutions and refining market access strategies.
As 2024 draws to a close, Archbow Consulting reflects on a year of dynamic change within the pharmaceutical industry.
As the world becomes increasingly digitized, a novel idea of a virtual third-party logistics (3PL) vendor has been established in the pharmaceutical industry.
Navigate the open road ahead with confidence. Start planning today and ensure your 2025 program delivers the support your patients need.
Pre-Asembia Checklist for Market Access Teams
A First-Hand Account of 3PLs – A Podcast on Distribution Best Practices
Essential Takeaways from the 2024 ECRM Conference
Revving Up for 2024: Market Access Kick-Start Resources
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
As seen in Pharmaceutical Commerce: Key considerations for drug manufacturers pursuing an effective alternative distribution model
Good vs. Excellent: How to Maximize Your 3PL Partnership
3PL Health Checks Generate Savings for Manufacturers: Here’s How to Begin
Essential Program Takeaways from the 2023 ECRM Conference
Our experts teamed up with Pharmaceutical Executive to identify 10 Market Access Trends to Watch for in 2023, spanning patients, prescribers
How pharmaceutical manufacturers can efficiently and effectively get product into the hands of patients
Webinar Archive: Get answers to the eleven key questions that will help guide commercial teams in effectively launching specialty products.
With a carefully crafted approach, SPs & Manufacturers can enjoy partnerships that drive access, adherence, and overall program performance
When it comes to pharmacy network design, there is a careful balance between access and control.
Pharmacy dispensing network strategies are an essential linchpin in any product’s commercial success.
For manufacturers who haven’t started preparing for DSCSA D-Day, the “OH NO!” moment is here, but this article can help.
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today
The answers to these eleven questions will help guide commercial teams in effectively launching specialty products.
When approached strategically, contracting with SP networks can positively impact patient experience and the company’s bottom line.
A proven, reliable methodology for designing a specialty pharmacy network is essential to ensuring optimal patient access